-
公开(公告)号:US11285156B2
公开(公告)日:2022-03-29
申请号:US16438349
申请日:2019-06-11
Applicant: Amgen Inc.
Inventor: John Gordon Allen , Brian Alan Lanman , Jian Chen , Anthony B. Reed , Victor J. Cee , Longbin Liu , Patricia Lopez , Ryan Paul Wurz , Thomas T. Nguyen , Shon Booker , Jennifer Rebecca Allen , Margaret Chu-Moyer , Albert Amegadzie , Ning Chen , Clifford Goodman , Jonathan D. Low , Vu Van Ma , Ana Elena Minatti , Nobuko Nishimura , Alexander J. Pickrell , Hui-Ling Wang , Youngsook Shin , Aaron C. Siegmund , Kevin C. Yang , Nuria A. Tamayo , Mary Walton , Qiufen Xue
IPC: A61K31/497 , C07D241/04 , A61K31/519 , A61K31/551 , A61K39/395 , A61P35/00
Abstract: Provided herein are KRAS G12C inhibitors, such as composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
-
公开(公告)号:US20250059205A1
公开(公告)日:2025-02-20
申请号:US18696946
申请日:2022-04-28
Applicant: AMGEN INC.
Inventor: Brian Alan Lanman , Ryan Paul Wurz , Wei Zhao , Xiaofen Li , Michael M. Yamano , Yunxiao Li , Ning Chen , Birgitte Weinreich Husemoen , Sebastian Leth-Petersen , Jose M. Medina , Kexue Li , Liping Pettus , Rene Rahimoff , Primali Vasundera Navaratne , Huan Rui , Christopher P. Mohr
IPC: C07D519/00 , A61K31/4995 , A61K31/517 , C07D487/08
Abstract: The present disclosure provides compounds useful for the inhibition of KRAS G12D. The compounds have a general Formula I: (I) wherein the variables of Formula I are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, cancer.
-
公开(公告)号:US20240417412A1
公开(公告)日:2024-12-19
申请号:US18695688
申请日:2022-08-10
Applicant: AMGEN INC.
Inventor: Brian Alan Lanman , Wei Zhao , Ryan Paul Wurz , Primali Vasundera NAVARATNE , Liping PETTUS , Michael M. YAMANO , Ning Chen , Rene RAHIMOFF , Francesco MANONI , John STELLWAGEN
IPC: C07D519/00 , A61K31/519 , A61K31/5377 , A61K31/553
Abstract: The present disclosure provides compounds useful for the inhibition of KRAS G12D. The compounds have a general Formula I: wherein the variables of Formula I are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, cancer.
-
公开(公告)号:US11090304B2
公开(公告)日:2021-08-17
申请号:US16402538
申请日:2019-05-03
Applicant: Amgen Inc.
Inventor: John Gordon Allen , Jennifer Rebecca Allen , Ana Elena Minatti , Qiufen Xue , Ryan Paul Wurz , Christopher M. Tegley , Alexander J. Pickrell , Thomas T. Nguyen , Vu Van Ma , Patricia Lopez , Longbin Liu , David John Kopecky , Michael J. Frohn , Ning Chen , Jian Jeffrey Chen , Aaron C. Siegmund , Albert Amegadzie , Nuria A. Tamayo , Shon Booker , Clifford Goodman , Mary Walton , Nobuko Nishimura , Youngsook Shin , Jonathan D. Low , Victor J. Cee , Anthony B. Reed , Hui-Ling Wang , Brian Alan Lanman
IPC: A61K31/517 , A61P35/00 , A61K31/4985 , A61K39/395 , C07D403/04 , C07D471/04
Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
-
公开(公告)号:US11053226B2
公开(公告)日:2021-07-06
申请号:US16687546
申请日:2019-11-18
Applicant: Amgen Inc.
Inventor: Youngsook Shin , Victor J. Cee , Christopher M. Tegley , Brian Alan Lanman , Ryan Paul Wurz , Kevin C. Yang , Vu Van Ma , Daniel Erlanson , Joon Won Jeong , Raymond V. Fucini , Jeffrey Iwig
IPC: C07D403/14 , C07D401/14 , C07D403/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D498/04 , A61P35/00
Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
-
公开(公告)号:US10988485B2
公开(公告)日:2021-04-27
申请号:US16407889
申请日:2019-05-09
Applicant: Amgen Inc.
Inventor: Ana Elena Minatti , Jonathan Dante Low , Ryan Paul Wurz , Brian Alan Lanman , Victor J. Cee , Michael D. Bartberger , Margaret Chu-Moyer
IPC: C07D513/04 , A61K45/06 , C07K16/28
Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
-
公开(公告)号:US10519146B2
公开(公告)日:2019-12-31
申请号:US15984855
申请日:2018-05-21
Applicant: Amgen Inc.
Inventor: Brian Alan Lanman , Jian Chen , Anthony B. Reed , Victor J. Cee , Longbin Liu , David John Kopecky , Patricia Lopez , Ryan Paul Wurz , Thomas T. Nguyen , Shon Booker , Nobuko Nishimura , Youngsook Shin , Nuria A. Tamayo , John Gordon Allen , Jennifer Rebecca Allen
IPC: C07D471/04 , C07D487/04 , C07D403/04 , C07D401/04 , C07D475/00 , A61K31/496 , A61K31/519 , A61P35/00 , C07D417/04 , A61K38/07 , C07D487/08 , C07D417/12 , C07D513/04 , C07D487/10 , C07D239/80 , C07D401/14 , C07D237/34 , A61K31/416 , A61K31/55 , A61K31/454 , A61K31/517 , A61K31/502 , A61K31/5025 , A61K31/7068 , C07D275/04
Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
-
-
-
-
-
-